Clinical use and safety of empiric anticoagulation during diagnostic work-up for deep vein thrombosis
Most patients received sub-therapeutic doses of empiric LMWH. Bleeding complications were low, indicating that empiric anticoagulation was safe. Empiric anticoagulation was often prescribed irrespective of the pre-test probability score and the bleeding risk.<b>Trial registration:</b> ClinicalTrials.gov identifier: NCT02486445.
Authors
- Camilla Tøvik Jørgensen (ORCID: https://orcid.org/0000-0002-0735-6611)
- Mazdak Tavoly (ORCID: https://orcid.org/0000-0002-5826-2631)
- Hodo Mohamad (ORCID: https://orcid.org/0000-0001-7752-6711)
- Waleed Ghanima (ORCID: https://orcid.org/0000-0003-2225-6165)
- Synne G. Fronas (ORCID: https://orcid.org/0000-0002-1748-0632)
Institutions
- University of Oslo (NO)
- Sahlgrenska University Hospital (SE)
- Østfold Hospital Trust (NO)
Publication Details
- Journal
- Hematology
- Published
- 2025-10-20
- DOI
- https://doi.org/10.1080/16078454.2025.2573586
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00